Find us at the Antibody Engineering & Therapeutics Europe 2025, the premier event advancing antibody discovery and engineering. From June 10-12, 2025, industry leaders, scientists, and innovators will gather in Basel, Switzerland, to explore breakthrough research and cutting-edge solutions driving the next generation of antibody therapeutics.
With 9 focused session themes, 350+ experts, and 30+ exhibitors, this is your opportunity to engage with the brightest minds in antibody research. Our team will be showcasing how our game-changing picodroplet microfluidic technology accelerates antibody discovery, streamlines workflows, and enhances engineering precision.
If you’re attending, don’t miss the chance to connect with us! Book a meeting with our team to explore how we can support your research and drive your discoveries forward.
POSTER PRESENTATION
Simona Preikšaitė
Senior Field Application Scientist
Sphere Bio
Abstract
Antibody drug development is costly and complex. Sphere Bio’s next-gen Cyto-Mine® Chroma system accelerates Antibody Discovery using picodroplet technology and multi-laser single-cell analysis. It enables rapid functional assessment of viability, productivity, and fluorescence followed by sorting and isolation of high value cells.
Cyto-Mine® Chroma’s high-throughput screening of millions of single cells per day streamlines screening and significantly accelerates therapeutic development.
